Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  236.48
-6.48 (-2.67%)
AAPL  269.71
-0.30 (-0.11%)
AMD  239.94
-6.33 (-2.57%)
BAC  53.99
-0.04 (-0.07%)
GOOG  341.35
-3.55 (-1.03%)
META  690.52
-15.88 (-2.25%)
MSFT  411.63
-11.74 (-2.77%)
NVDA  179.18
-6.44 (-3.47%)
ORCL  152.88
-7.18 (-4.49%)
TSLA  417.53
-4.28 (-1.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.